| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0009 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |